China Traditional Chinese Medicine Holdings Co. Limited (Hong Kong SAR, China)

China Traditional Chinese Medicine Holdings Co. Limited, also known as China Traditional Chinese Medicine, is the core platform of the Traditional Chinese Medicine industry sector of China National Pharmaceutical Group Corporation (Sinopharm). The company is listed on the Main Board of the Hong Kong Stock Exchange (stock code: 00570.HK) and has its headquarters in Foshan, Guangdong. With approximately 18,000 employees, the company owns over 100 subsidiaries. China Traditional Chinese Medicine has a comprehensive industrial chain that integrates research, manufacturing, and sales. It offers over 800 proprietary Chinese medicine products (including more than 280 products listed in the 2018 edition of the National Essential Medicines List), over 700 single-herb Chinese medicine granule formulations, and over 400 classic compound concentrated granules (for export). Its business covers various areas including Chinese medicinal materials cultivation, Chinese herbal pieces, granule formulations, Chinese patent medicines, and traditional Chinese medicine health. The company inherits the essence of traditional Chinese medicine, spanning over 400 years of history. It carries the legacy of renowned brands such as "Liangzhonghong Pill Store," "Fengliaoxing," "Tongjitang," and "Yuanjilin." It possesses three Chinese time-honored brands, namely "Fengliaoxing," "Anning," and "Tongjitang," as well as five well-known trademarks, including "Xianling," "Tongjitang," "Xianling Bone Bao," "Tianjiang Pharmaceutical," and "Dezhong." It also holds four intangible cultural heritages, namely "Tongjitang Traditional Chinese Medicine Culture," "Fengliaoxing Rheumatism Liniment," "Shaolin Trauma Liniment," and "Yuanjilin Ganhe Tea," as well as ten exclusive national essential drugs, such as "Xianling Bone Bao Capsule," "Jingshu Granule," "Fengshi Bone Pain Capsule," "Qili Capsule," "Moisturizing and Itching Relief Capsule," "Zaoren Anshen Capsule," "Yupingfeng Granule," "Biyankang Tablet," "Jinye Detoxification Granule," and "Biejia Decoction Pill." China Traditional Chinese Medicine always prioritizes quality and has earned the trust of doctors and patients with its high-quality brands and products. The company's mission is to "implement the national development strategy for traditional Chinese medicine and lead the high-quality development of the Chinese medicine industry." It focuses on industrialization, supported by technology, and vigorously develops the medicinal materials resource industry. It fully leverages its traditional trade advantages and actively enters the value-added service field of traditional Chinese medicine health. China Traditional Chinese Medicine aims to become a leader in the Chinese medicine industry and share a billion-dollar Chinese medicine platform with various sectors.